Patents by Inventor Jake J. Cotter

Jake J. Cotter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230250390
    Abstract: Methods and compositions herein provide non-naturally occurring ?-butyrolactones (GBLs) in racemic mixtures that increase efficiency and effectiveness of screening for production of antibiotics, and enhance yields and express silent pathways. Non-naturally occurring GBLs were synthesized and found to stimulate antibiotic production in several different streptomycete strains. Antibiotic production by Streptomyces coelicolor was induced by a racemic mixture of non-cognate stereoisomers of VB-D, seven of which are non-naturally occurring. Further, novel A-factor-type GBL analogs stimulated antibiotic production in S. coelicolor. Synthesis in response to the treatment with the non-cognates GBL was observed for known compounds including undecylprodigiosin, desferrioxamine and streptorubin B, as was synthesis of a compound of unknown structure.
    Type: Application
    Filed: September 19, 2022
    Publication date: August 10, 2023
    Applicant: Prospective Research, Inc.
    Inventors: Dakota Benjamin Hamill, Jake J. Cotter
  • Patent number: 11447742
    Abstract: Methods and compositions herein provide non-naturally occurring ?-butyrolactones (GBLs) in racemic mixtures that increase efficiency and effectiveness of screening for production of antibiotics, and enhance yields and express silent pathways. Non-naturally occurring GBLs were synthesized and found to stimulate antibiotic production in several different streptomycete strains. Antibiotic production by Streptomyces coelicolor was induced by a racemic mixture of non-cognate stereoisomers of VB-D, seven of which are non-naturally occurring. Further, novel A-factor-type GBL analogs stimulated antibiotic production in S. coelicolor. Synthesis in response to the treatment with the non-cognates GBL was observed for known compounds including undecylprodigiosin, desferrioxamine and streptorubin B, as was synthesis of a compound of unknown structure.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: September 20, 2022
    Assignee: Prospective Research, Inc.
    Inventors: Dakota Benjamin Hamill, Jake J. Cotter
  • Publication number: 20180346871
    Abstract: Methods and compositions herein provide non-naturally occurring ?-butyrolactones (GBLs) in racemic mixtures that increase efficiency and effectiveness of screening for production of antibiotics, and enhance yields and express silent pathways. Non-naturally occurring GBLs were synthesized and found to stimulate antibiotic production in several different streptomycete strains. Antibiotic production by Streptomyces coelicolor was induced by a racemic mixture of non-cognate stereoisomers of VB-D, seven of which are non-naturally occurring. Further, novel A-factor-type GBL analogs stimulated antibiotic production in S. coelicolor. Synthesis in response to the treatment with the non-cognates GBL was observed for known compounds including undecylprodigiosin, desferrioxamine and streptorubin B, as was synthesis of a compound of unknown structure.
    Type: Application
    Filed: August 9, 2018
    Publication date: December 6, 2018
    Applicant: Prospective Research, Inc.
    Inventors: Dakota Benjamin Hamill, Jake J. Cotter